Characteristics of 4 000 patients in a French cohort with angina pectoris: The ELAN study;Caracteristiques d'une cohorte Francaise de 4 000 patients angineux l'etude ELAN

Archives des Maladies du Coeur et des Vaisseaux

Volumn 93, Issue 3, 2000, Pages 219-226

  Guize, L ^b   Ducimetiere P ^b   Consoli, S M ^b   Kolsky, H ^b   Raynaud, P ^b   Walch, J M ^b   Paul Dauphin, A ^b   Duprat Lomon, I ^a  

^a HÔPITAL BROUSSAIS   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; AMIODARONE; ANTIANGINA PECTORIS AGENT; ANTIDEPRESSANT AGENT; ANTILIPEMIC AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; ANXIOLYTIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; DIGITALIS; DIHYDROPYRIDINE DERIVATIVE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FIBRIC ACID DERIVATIVE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; HYPNOTIC SEDATIVE AGENT; NITRATE;

ADULT; AGED; ANGINA PECTORIS; ANXIETY NEUROSIS; ARTICLE; CARDIOVASCULAR DISEASE; COHORT ANALYSIS; CORONARY ARTERY BYPASS SURGERY; CORONARY ARTERY DISEASE; DEPRESSION; FEMALE; HEART INFARCTION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; TRANSLUMINAL CORONARY ANGIOPLASTY; ANGIOCARDIOGRAPHY; DEMOGRAPHY; EXERCISE TEST; HEART MUSCLE REVASCULARIZATION; METHODOLOGY; MIDDLE AGED; PROGNOSIS;

ADULT; AGED; AGED, 80 AND OVER; ANGINA PECTORIS; COHORT STUDIES; CORONARY ANGIOGRAPHY; DEMOGRAPHY; EXERCISE TEST; FEMALE; HUMANS; HYPERCHOLESTEROLEMIA; HYPERTENSION; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL REVASCULARIZATION; PROGNOSIS; RESEARCH DESIGN;

EID: 0034061144     PISSN: 00039683     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Pyörälä K, de Backer G, Graham I, Poole-Wilson P, Wood D. on behalf of the Task Force. Prevention of coronary heart disease in clinical practice. Recommendations of the Task Force of the European Society of Cardiology, European Atherosclerosis Society and European Society of Hypertension. Eur Heart J 1994 ; 15 : 1300-31.
2. Ducimetière P, Richard JL, Claude J.R, Warnet J.M. Les cardiopathies ischémiques. Incidence et facteurs de risque. L'Étude Prospective Parisienne. Les Éditions INSERM, Paris, 1981.
3. Ferrières J, Cambou JP, Ruidavets JB, Pous J. Trends in acute myocardial infarction prognosis and treatment in Southwestern France between 1985 and 1990 (The MONICA Project-Toulouse). Am J Cardiol 1995 ; 75 : 1202-5.
4. Fender M, Arveiler D, Facello A. Vers une diminution de l'infarctus du myocarde dans le Bas-Rhin ? Résultats des six premières années du registre MONICA Strasbourg. Ann Cardiol Angéiol 1994 ; 43 (7) : 373-9.
5. Cambou JP, Arveiler D, Amouyel Ph, Ruidavets JB, Haas B. Montayé M, Bingham A, Richard JL. La maladie coronaire en France : données des registres MONICA (1985-1991). Rev Epidém Santé Publ 1996 ; 44 : S46-S52.
6. Ducimetière P, Richard JL, Cambien F, Rakotavao RC, Claude JR. Coronary heart disease in middle-aged Frenchmen. Comparison between Paris Prospective Study, Seven Countries Study and Pooling Project. Lancet 1980 ; 1 : 1346-9.
7. Tunstall-Pedoe H, Kuulasmaa K, Amouyel P, Arveiler D, Rajakangas AM, Pajak A. Myocardial infarction and coronary deaths in the World Health Organization MONICA project. Registration procedures, events rates and case-fatality rates in 38 populations from 21 countries in four continents. Circulation 1994 ; 90 : 583-612.
8. European Coronary Surgery Study Group. Long-term results of prospective randomised study of coronary artery bypass surgery in stable angina pectoris. Lancet 1982 ; 2 : 1173-80.
9. CASS principal investigators and their associates. Coronary Artery Surgery Study (CASS): A randomised trial of coronary artery bypass surgery: Survival Data. Circulation 1983 ; 68 : 939-50.
10. The TIBET Study Group. The Total Ischemic Burden European Trial (TIBET): Design, Methodology and Management. Cardiovasc Drugs Ther 1992 ; 6 : 379-86.
11. Scandinavian Simvastatine Survival Study Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994 ; 344 :1383-9.
12. Thompson SG, Kienast J, Pyke SDM, M. SC, Haverkate F, Van de Loo JCW. Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. N Engl J Med 1995 ; 332 (10) : 635-41.
13. Sigurdsson E, Sigfusson N, Agnarsson U, Sigvaldason H, Thorgeirsson G. Long-term prognosis of different forms of coronary heart disease: The Reykjavik Study. Int J Epidemiol 1995 ; 24 : 58-68.
14. Gandhi MM, Lampe FC, Wood DA. Incidence, clinical characteristics, and short-term prognosis of angina pectoris. Br Heart J 1995 ; 73 : 193-8.
15. Campeau L. Grading of angina pectoris. Circulation 1976 ; 54 : 522-3.
16. Sarason IG, Levine HM, Basham RB, Sarason RB. Assessing social support: the social support questionnaire. J Pers Soc Psychol 1983 ; 44 : 127-39.
17. Buss AH, Durkee A. An inventory for assessing different kinds of hostility. J Consult Psychiatry 1957 ; 21 (4) : 343-9.
18. re partie : inventaires multidimensionnels. Psychiatr Psychobiol 1990 ; 5 : 49-63.
19. Pichat P, Boyer P, Pull CB, Rein W, Simon M, Thibault A. Le questionnaire QD 2. La forme abrégée QD 2A. Rev Psychol Appl 1984 ; 4 : 323-40.
20. Pepine CJ, Abrams J, Marks RG, Morris JJ, Scheidt SS, Handberg E, for the TIDES Investigators. Characteristics of a contemporary population with angina pectoris. Am J Cardiol 1994 ; 74 : 226-31.
21. Henry P, Makowski S, Guermonprez JL, Guize L. Étude comparée de quatre stratégies diagnostiques de la maladie coronaire. Arch Mal Cœur 1997 ; 90 (3) : 327-35.
22. Graille V, Ferrières J, Marques-Vidal P, Ruidavets JB, Rodier P, Cambou JP. Evolution à long terme de la prescription médicamenteuse chez 174 patients atteints d'infarctus du myocarde suivis pendant 4,5 ans (étude DEVENIR). Arch Mal Cœur 1996 ; 89 : 35-9.
23. EUROASPIRE Study Group. European Society of Cardiology survey of secondary prevention of coronary heart disease: Principal results. Eur Heart J 1997 ; 18 : 1569-82.
24. Boissel JP, Némoz C, Gillet J, Salewski B, Diaz N et al. La prescription médicamenteuse dans le postinfarctus : résultats de l'EPPI (étude de prescription postinfarctus), une étude coopérative française. Arch Mal Cœur 1990 ; 83 :1777-82.
25. Boissel JP, Némoz C, Leizorovicz A, Gillet J. La prescription médicamenteuse dans le postinfarctus ; résultats de l'EPPI II (étude de prescription postinfarctus). Arch Mal Cœur 1995 ; 89 : 1261-6.
26. Mood D, De Backer Guy, Faergeman O, Graham I, Mancia G, Pyörälä K, together with members of the Task Force. Prevention or coronary heart disease in clinical practice. Recommendations of the Second Joint Task Force of European and other Societies on Coronary Prevention. Eur Heart J 1998 ; 19 : 1434-503.
27. Management of stable angina pectoris: recommendations of the task force of the European Society of Cardiology. Eur Heart J 1997 ; 18 : 394-413.